OasisLMS

1. Apply new evidence and guidelines to personalize prostate cancer treatment across localized, hormone-sensitive, and castration-resistant disease.
2. Evaluate the role of imaging modalities (PSMA PET, MRI) and emerging biomarkers in diagnosis and monitoring.
3. Interpret genomic and AI-driven data to inform precision medicine decisions.
4. Incorporate strategies to manage ADT side effects and promote survivorship health.
5. Demonstrate collaborative and advocacy-based approaches to improve access, reimbursement, and quality of care in prostate oncology.
6. Integrate APP-directed and multidisciplinary models to enhance care efficiency and outcomes.
7. Engage patients and caregivers in shared decision-making to support holistic, compassionate care.